Global Medical Robots Market to Reach USD 16 Billion by 2023
|
By HospiMedica International staff writers Posted on 10 Aug 2018 |
The global medical robots market is projected to grow at a CAGR of 21.0% from an estimated USD 6.46 billion in 2018 to USD 16.74 billion by 2023, driven by technological advancements, advantages of robot-assisted training in rehabilitation therapy, increased funding for medical robot research, and IPOs issued by medical robot companies. However, safety concerns over robotic surgery devices are expected to limit the market growth to some extent. Recent studies have found a number of technical difficulties and complications experienced while performing procedures using robotic systems. According to the FDA, from 2000 to 2013, surgical robots have been linked to over 144 deaths, over 1,391 injuries, and 8,061 device malfunctions.
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
Based on product, the instruments & accessories segment held the largest share of the medical robots market in 2017, while the surgical robotic systems sub-segment accounted for the largest share of the robotic systems market. In 2017, the laparoscopy robotic systems segment accounted for the largest share of the global surgical robotic systems market and is also expected to register the highest CAGR during the forecast period. This can be attributed to the benefits of robotic laparoscopy systems such as greater stability in comparison to the human hand, lower number of incisions, and better visual magnification. Generally, robotic surgeries result in lesser pain, shorter hospital stays, and faster recovery of patients.
On the basis of application, the laparoscopy segment accounted for the largest share of the global medical robots market in 2017 due to the growing volume of laparoscopic surgeries performed across the world. However, the neurosurgery segment is projected to register the highest CAGR during the forecast period due to the increasing precision and improved quality of medical robots that is encouraging the use of robots in neurosurgery.
Geographically, North America dominated the global medical robots market with the largest share due to the increasing adoption of surgical robots by hospitals in the region, favorable funding scenario for research on medical robots, and availability of technologically advanced medical robots. However, Asia Pacific is expected to register the highest CAGR during the forecast period, driven by its growing geriatric population, increasing adoption of medical robots, and robot-assisted training initiatives for surgeons.
Related Links:
Research and Markets
These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.
Based on product, the instruments & accessories segment held the largest share of the medical robots market in 2017, while the surgical robotic systems sub-segment accounted for the largest share of the robotic systems market. In 2017, the laparoscopy robotic systems segment accounted for the largest share of the global surgical robotic systems market and is also expected to register the highest CAGR during the forecast period. This can be attributed to the benefits of robotic laparoscopy systems such as greater stability in comparison to the human hand, lower number of incisions, and better visual magnification. Generally, robotic surgeries result in lesser pain, shorter hospital stays, and faster recovery of patients.
On the basis of application, the laparoscopy segment accounted for the largest share of the global medical robots market in 2017 due to the growing volume of laparoscopic surgeries performed across the world. However, the neurosurgery segment is projected to register the highest CAGR during the forecast period due to the increasing precision and improved quality of medical robots that is encouraging the use of robots in neurosurgery.
Geographically, North America dominated the global medical robots market with the largest share due to the increasing adoption of surgical robots by hospitals in the region, favorable funding scenario for research on medical robots, and availability of technologically advanced medical robots. However, Asia Pacific is expected to register the highest CAGR during the forecast period, driven by its growing geriatric population, increasing adoption of medical robots, and robot-assisted training initiatives for surgeons.
Related Links:
Research and Markets
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







